Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-92.67%
operating margin TTM
-90.54%
revenue TTM
284.43 Million
revenue per share TTM
4.71$
valuation ratios | |
|---|---|
| pe ratio | -26.56 |
| peg ratio | -2.79 |
| price to book ratio | -47.81 |
| price to sales ratio | 24.76 |
| enterprise value multiple | -35.87 |
| price fair value | -47.81 |
profitability ratios | |
|---|---|
| gross profit margin | 85.3% |
| operating profit margin | -90.54% |
| pretax profit margin | -91.75% |
| net profit margin | -92.67% |
| return on assets | -32.19% |
| return on equity | 191.42% |
| return on capital employed | -189.75% |
liquidity ratio | |
|---|---|
| current ratio | 1.04 |
| quick ratio | 0.71 |
| cash ratio | 0.58 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 1,973.41 |
| operating cycle | 2,049.46 |
| days of payables outstanding | 568.11 |
| cash conversion cycle | 1,481.35 |
| receivables turnover | 4.80 |
| payables turnover | 0.64 |
| inventory turnover | 0.18 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.80 |
| debt equity ratio | -4.46 |
| long term debt to capitalization | 2.13 |
| total debt to capitalization | 1.29 |
| interest coverage | -10.08 |
| cash flow to debt ratio | -0.26 |
cash flow ratios | |
|---|---|
| free cash flow per share | -3.68 |
| cash per share | 8.63 |
| operating cash flow per share | -3.65 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -0.26 |
| short term coverage ratios | -0.45 |
| capital expenditure coverage ratio | -113.38 |
Frequently Asked Questions
When was the last time Ascendis Pharma A/S (NASDAQ:ASND) reported earnings?
Ascendis Pharma A/S (ASND) published its most recent earnings results on 01-05-2025.
What is Ascendis Pharma A/S's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Ascendis Pharma A/S (NASDAQ:ASND)'s trailing twelve months ROE is 191.42%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Ascendis Pharma A/S (ASND) currently has a ROA of -32.19%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ASND's net profit margin stand at?
ASND reported a profit margin of -92.67% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ASND's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.04 in the most recent quarter. The quick ratio stood at 0.71, with a Debt/Eq ratio of -4.46.